Posted by Michael Wonder on 04 May 2023
Federal funding for discovery and development of costly HIV drugs was far more than previously estimated
1 May 2023 - In July 2012, tenofovir disoproxil fumarate-emtricitabine (Truvada) was approved by the FDA to prevent HIV infection.
To estimate the extent of the US Government’s direct financial contribution to the discovery and development of Truvada, we identified National Institutes of Health awards using FDA documents, peer-reviewed literature, patent records, court filings, and other publicly available materials.
